← Medical directoryActive ingredient
Kayshild (semaglutide)
Brand name for once-weekly semaglutide 2.4 mg, which has held conditional marketing authorisation in the EU since 26 March 2026 for non-cirrhotic MASH with F2–F3 fibrosis, alongside diet and exercise. It is a GLP-1 agonist.
Institutional endorsement by Clínica Evolution
This entry is for information. Your case requires an individual medical assessment.





